OR WAIT null SECS
August 02, 2012
The author discusses strategies for preventing cargo theft.
Approaches to scaling up API syntheses center on ways to optimize process conditions and operability.
Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing.
Enhancing bioavailability can be achieved through hot-melt extrusion or spray drying. Patricia Van Arnum interviews Bend Research to find out more about when to use each technique.
August 01, 2012
The manufacturing capacity-sharing model in biologics and Merck & Co. and MedImmune ushers in a new paradigm of "co-opetition".
An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.
July 11, 2012
Flow chemistry and microreactors offer an alternative to traditional batch manufacturing.
July 02, 2012
Holistic open learning networks offer a new drug R&D model for improving research outcomes.
Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors.
The past three decades have driven a purchasing evolution to a procurement revolution.